Medtronic plc completed the spin-off of MiniMed Group, Inc. and redeemed its remaining interest, marking a major strategic milestone.
MDT news
Latest 6 stories · newest Oct 19, 2026
Orchestra BioMed has surpassed its target of 316 patients in the pivotal BACKBEAT trial. Full enrollment positions the company to submit primary endpoint data in late 2027, supporting Medtronic's future FDA applications for AVIM Therapy.
Medtronic reported $9.8 billion in Q1 FY27 revenue and raised organic growth and EPS guidance, driven by broad portfolio strength.
Medtronic delivered 8.4% reported revenue growth and 5.8% organic growth in fiscal 2026, with Q4 revenue of $9.8B exceeding guidance. The company increased its dividend for the 49th consecutive year and completed strategic M&A transactions including CathWorks acquisition while filing for FDA approva…
The same MDT feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/MDT/newsSTART FREE